GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Epigenomics AG (OTCPK:EPGNF) » Definitions » E10

Epigenomics AG (Epigenomics AG) E10 : $-64.13 (As of Jun. 2023)


View and export this data going back to . Start your Free Trial

What is Epigenomics AG E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Epigenomics AG's adjusted earnings per share data for the three months ended in Jun. 2023 was $-3.359. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-64.13 for the trailing ten years ended in Jun. 2023.

During the past 3 years, the average E10 Growth Rate was 14.70% per year. During the past 5 years, the average E10 Growth Rate was 7.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Epigenomics AG was 14.70% per year. The lowest was -1.30% per year. And the median was 8.30% per year.

As of today (2024-05-16), Epigenomics AG's current stock price is $2.50. Epigenomics AG's E10 for the quarter that ended in Jun. 2023 was $-64.13. Epigenomics AG's Shiller PE Ratio of today is .


Epigenomics AG E10 Historical Data

The historical data trend for Epigenomics AG's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epigenomics AG E10 Chart

Epigenomics AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -124.64 -130.10 -140.23 -89.20 -75.35

Epigenomics AG Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -68.43 -81.18 -75.35 -82.99 -64.13

Competitive Comparison of Epigenomics AG's E10

For the Diagnostics & Research subindustry, Epigenomics AG's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Epigenomics AG's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Epigenomics AG's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Epigenomics AG's Shiller PE Ratio falls into.



Epigenomics AG E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Epigenomics AG's adjusted earnings per share data for the three months ended in Jun. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=-3.359/123.1404*123.1404
=-3.359

Current CPI (Jun. 2023) = 123.1404.

Epigenomics AG Quarterly Data

per share eps CPI Adj_EPS
201309 -29.343 98.983 -36.504
201312 -31.946 99.356 -39.593
201403 -32.255 99.543 -39.901
201406 -25.453 99.543 -31.487
201409 -25.998 99.823 -32.071
201412 -37.314 99.543 -46.160
201503 -31.191 99.717 -38.518
201506 -24.260 100.417 -29.750
201509 -22.643 100.417 -27.767
201512 -6.279 99.717 -7.754
201603 -36.909 100.017 -45.442
201606 -25.906 100.717 -31.674
201609 -17.791 101.017 -21.687
201612 -7.600 101.217 -9.246
201703 -15.412 101.417 -18.713
201706 -29.145 102.117 -35.145
201709 -8.588 102.717 -10.296
201712 -17.810 102.617 -21.372
201803 -24.452 102.917 -29.257
201806 -19.602 104.017 -23.206
201809 -21.359 104.718 -25.117
201812 -21.803 104.217 -25.762
201903 -14.248 104.217 -16.835
201906 -20.802 105.718 -24.230
201909 -12.151 106.018 -14.113
201912 -30.866 105.818 -35.919
202003 -11.974 105.718 -13.947
202006 -12.590 106.618 -14.541
202009 -11.072 105.818 -12.885
202012 -10.462 105.518 -12.209
202103 -4.762 107.518 -5.454
202106 -5.060 108.486 -5.744
202109 3.765 109.435 4.237
202112 -3.333 110.384 -3.718
202203 -3.634 113.968 -3.926
202206 -1.691 115.760 -1.799
202209 -1.980 118.818 -2.052
202212 -8.475 119.345 -8.745
202303 -7.013 122.402 -7.055
202306 -3.359 123.140 -3.359

Add all the adjusted EPS together and divide 10 will get our e10.


Epigenomics AG  (OTCPK:EPGNF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Epigenomics AG E10 Related Terms

Thank you for viewing the detailed overview of Epigenomics AG's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Epigenomics AG (Epigenomics AG) Business Description

Traded in Other Exchanges
Address
Geneststrasse 5, Berlin, BB, DEU, 10829
Epigenomics AG is a molecular diagnostics company, that focuses on developing and commercializing in vitro diagnostic liquid biopsy tests for the screening, early detection, and diagnosis of cancer. The company develops and markets procedures and devices for the production in quantity of particular epigenetic parameters such as DNA methylation patterns as well as the information technology bases necessary for their procurement and evaluation. It is engaged in the development of novel molecular diagnostic products for cancer. The company products include Epi proColon, Epi BiSKit, HCCBloodTest, and Epi proLung. The company operates in Europe, Asia, and North America, majority of its revenue derives from Asia.

Epigenomics AG (Epigenomics AG) Headlines